News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,765 Results
Type
Article (14452)
Company Profile (114)
Press Release (350199)
Multimedia
Podcasts (37)
Webinars (7)
Section
Business (112664)
Career Advice (456)
Deals (18613)
Drug Delivery (29)
Drug Development (31178)
Employer Resources (50)
FDA (8794)
Job Trends (7674)
News (172790)
Policy (12363)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (1325)
Accelerated approval (3)
Allergies (40)
Alliances (34804)
ALS (25)
Alzheimer's disease (512)
Antibody-drug conjugate (ADC) (66)
Approvals (8821)
Artificial intelligence (236)
Autoimmune disease (4)
Automation (12)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (12)
Breast cancer (115)
Cancer (990)
Cardiovascular disease (62)
Career advice (406)
Career pathing (8)
CAR-T (101)
Cell therapy (263)
Cervical cancer (10)
Clinical research (24472)
Collaboration (589)
Compensation (111)
Complete response letters (3)
COVID-19 (1148)
CRISPR (36)
C-suite (140)
Cystic fibrosis (47)
Data (944)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (99)
Diagnostics (4906)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (23)
Earnings (38664)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51272)
Executive appointments (391)
FDA (9415)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (465)
Gene editing (84)
Generative AI (24)
Gene therapy (167)
GLP-1 (225)
Government (1234)
Grass and pollen (2)
Guidances (26)
Healthcare (9894)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (29)
Indications (11)
Infectious disease (1224)
Inflammatory bowel disease (62)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (59)
Interviews (51)
IPO (8008)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (117)
Leadership (3)
Legal (2523)
Liver cancer (34)
Lung cancer (125)
Lymphoma (59)
Machine learning (3)
Management (17)
Manufacturing (176)
MASH (15)
Medical device (11475)
Medtech (11480)
Mergers & acquisitions (10946)
Metabolic disorders (210)
Multiple sclerosis (26)
NASH (3)
Neurodegenerative disease (30)
Neuropsychiatric disorders (3)
Neuroscience (701)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1065)
Now hiring (8)
Obesity (88)
Opinion (77)
Ovarian cancer (39)
Pain (47)
Pancreatic cancer (40)
Parkinson's disease (67)
Partnered (12)
Patents (141)
Patient recruitment (52)
Peanut (26)
People (32750)
Pharmaceutical (16)
Phase I (9022)
Phase II (11040)
Phase III (7165)
Pipeline (536)
Policy (28)
Postmarket research (501)
Preclinical (4075)
Press Release (66)
Prostate cancer (41)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (133)
Real estate (3365)
Recruiting (20)
Regulatory (9371)
Reports (18)
Research institute (1269)
Resumes & cover letters (68)
Rett syndrome (3)
RNA editing (2)
RSV (23)
Schizophrenia (12)
Series A (84)
Series B (50)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1158)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2506)
State (2)
Stomach cancer (2)
Supply chain (25)
Tariffs (1)
The Weekly (18)
United States (11247)
Vaccines (317)
Venture capitalists (19)
Weight loss (36)
Women's health (17)
Worklife (2)
Date
Last 7 days (253)
Last 30 days (1065)
Last 365 days (17242)
2025 (4814)
2024 (18710)
2023 (22099)
2022 (30813)
2021 (32514)
2020 (30545)
2019 (25809)
2018 (19470)
2017 (18877)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12743)
2012 (13783)
2011 (14071)
2010 (12831)
Location
Africa (318)
Alabama (40)
Alaska (6)
Arizona (123)
Arkansas (10)
Asia (24038)
Australia (4186)
California (2811)
Canada (1024)
China (235)
Colorado (161)
Connecticut (128)
Delaware (42)
Europe (49132)
Florida (461)
Georgia (136)
Idaho (33)
Illinois (277)
India (12)
Indiana (158)
Iowa (4)
Japan (106)
Kansas (82)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (446)
Massachusetts (1964)
Michigan (183)
Minnesota (243)
Mississippi (2)
Missouri (58)
Montana (24)
Nebraska (15)
Nevada (20)
New Hampshire (66)
New Jersey (891)
New Mexico (16)
New York (832)
North Carolina (515)
North Dakota (7)
Northern California (1065)
Ohio (100)
Oklahoma (11)
Oregon (19)
Pennsylvania (575)
Puerto Rico (9)
Rhode Island (24)
South America (506)
South Carolina (18)
South Dakota (1)
Southern California (1158)
Tennessee (60)
Texas (455)
Utah (103)
Virginia (55)
Washington D.C. (11)
Washington State (327)
West Virginia (3)
Wisconsin (36)
364,765 Results for "palatin technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
April 17, 2025
·
6 min read
Press Releases
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
April 11, 2025
·
7 min read
Press Releases
Palatin Provides Update on Anticipated 2025 Corporate Milestones
January 28, 2025
·
6 min read
Press Releases
Palatin’s Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency
March 26, 2025
·
6 min read
Press Releases
Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
March 31, 2025
·
10 min read
Press Releases
Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
April 1, 2025
·
9 min read
Press Releases
Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
February 7, 2025
·
5 min read
Press Releases
Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
February 14, 2025
·
12 min read
Drug Development
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced the initiation of a Phase 2 clinical study of bremelanotide for the treatment of obesity.
June 12, 2024
·
6 min read
Drug Development
Palatin’s Dry Eye Drug Candidate Flops in Phase III Trial
Palatin Technologies’ melanocortin agonist PL9643 came up short in a late-stage study evaluating its safety and efficacy.
March 1, 2024
·
2 min read
·
Tyler Patchen
1 of 36,477
Next
